Position in NAGE
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$4,723,696
-$1,129,854 QoQ
Shares Held
1,071,133
+16.4% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 91%
Shared 4%
None 5%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. NAGE ranks #97 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in NAGE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,723,696 | 1,071,133 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $5,853,550 | 920,370 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,770,993 | 725,723 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,941,159 | 342,898 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,249,582 | 181,099 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $652,714 | 122,922 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $248,027 | 67,953 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $87,662 | 32,111 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||